Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Well it hasn’t varied at all over the last 15 years, which I find pretty amazing because we’ve been through a lot of changes in general practice. Yet, the average length of consultation, as measured from a start to finish time, in a sample of 40,000 consultations in Australia in a year, shows that the average is 15 minutes and the median is 13 minutes.

4 Mar 2013

Clothing closely linked to peak performance for skiers

The sport of cross-country skiing has always been preoccupied with its skis and waxing. Research now demonstrates that to shave off those extra hundredths of a second, competitive skiers should pay more attention to their clothing.

3 Mar 2013

Significant link between defective viruses and increased rate of transmission of major disease

Defective viruses, thought for decades to be essentially garbage unrelated to the transmission of normal viruses, now appear able to play an important role in the spread of disease, new research by UCLA life scientists indicates.

2 Mar 2013

Combination of two environmental factors contributes to schizophrenia

The interplay between an infection during pregnancy and stress in puberty plays a key role in the development of schizophrenia, as behaviourists from ETH Zurich demonstrate in a mouse model. However, there is no need to panic.

2 Mar 2013

India needs political leadership, resources to ensure children's right to health

"India is making positive strides in reducing child mortality through new policies and ambitious programs, but preventing the deaths of millions of children remains one of the country's greatest challenges," health expert and blogger John Butler writes in the Wall Street Journals "India Real Time" blog, noting, "Roughly 1.7 million children under five years old die every year in India, says UNICEF, representing more than a fifth of all child deaths worldwide."

2 Mar 2013

Influenza vaccine linked to narcolepsy in children in England

Researchers have found an increased risk for narcolepsy in children who received the swine flu vaccination in England.

1 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

"When U.N. Secretary-General Ban Ki-moon invoked diplomatic immunity last week for peacekeepers who unwittingly caused the cholera outbreak that killed nearly 8,000 Haitians, his decision looked cold-hearted," but "sympathy for Haitians should not mask the necessity of the secretary-general's decision," Boston Globe correspondent Juliette Kayyem writes in an opinion piece in the newspaper.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Steroids may reduce length of hospital stay in patients with pneumonia

Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients.

1 Mar 2013

Excess of vitamin D during pregnancy can increase risk of food allergy in children

Pregnant women should avoid taking vitamin D supplements. Substitution appears to raise the risk of children developing a food allergy after birth.

28 Feb 2013

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides, Inc., announced today that it has retired the remainder of the Series C Convertible Preferred Stock previously purchased by Seaside 88, LP, with a cash payment.

27 Feb 2013

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.

27 Feb 2013

New research reveals special face masks prevent clinical respiratory and bacterial infections

Health care workers who consistently wear special fitted face masks while on duty are much less likely to get clinical respiratory and bacterial infections, according to new research led by University of New South Wales academics.

27 Feb 2013

Groups expect White House to propose new global food aid approach

"The White House may soon propose the biggest change in U.S. food aid since the programs were created during the Cold War -- donating cash for hunger relief instead of shipping American-grown food thousands of miles to global trouble spots, say farm groups and charities," Reuters reports.

27 Feb 2013

Truven Health Analytics names UCSD Medical Center in 100 Top Hospitals list

University of California, San Diego Medical Center has been named one of the nation's 100 Top Hospitals for the second time by Truven Health Analytics, formerly the health care business of Thomson Reuters.

27 Feb 2013

Princeton metabolic model can predict how parasites would fare in altered climates

Knowing the temperatures that viruses, bacteria, worms and all other parasites need to grow and survive could help determine the future range of infectious diseases under climate change, according to new research.

27 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Clothing closely linked to peak performance for skiers

Significant link between defective viruses and increased rate of transmission of major disease

Combination of two environmental factors contributes to schizophrenia

India needs political leadership, resources to ensure children's right to health

Influenza vaccine linked to narcolepsy in children in England

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Steroids may reduce length of hospital stay in patients with pneumonia

Excess of vitamin D during pregnancy can increase risk of food allergy in children

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

New research reveals special face masks prevent clinical respiratory and bacterial infections

Groups expect White House to propose new global food aid approach

Truven Health Analytics names UCSD Medical Center in 100 Top Hospitals list

Princeton metabolic model can predict how parasites would fare in altered climates

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in